MDRX — Veradigm Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid Cap

Annual balance sheet for Veradigm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	—	12 M	12 M	12 M
Source:	10-K	10-Q	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	531	133	447	447	294
Net Total Accounts Receivable
Net Total Receivables	479	235	176	198	199
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,153	1,554	680	699	546
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	169	28.1	21.4	—	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,918	2,425	1,505	1,573	1,352
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	935	598	230	446	422
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,251	1,017	487	498	548
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,666	1,408	1,018	1,074	804
Total Liabilities & Shareholders' Equity	2,918	2,425	1,505	1,573	1,352
Total Common Shares Outstanding